Treatment Outcome of Overactive Bladder Patients Receiving Antimuscarinic Therapy for More than One Year

E-ISSN： 1757-5672|10|1|21-26

ISSN： 1757-5664

Source： LUTS, Vol.10, Iss.1, 2018-01, pp. : 21-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does patient education increase antimuscarinic treatment persistence in overactive bladder syndrome?

INTERNATIONAL JOURNAL OF UROLOGICAL NURSING, Vol. 9, Iss. 2, 2015-07 ,pp. : 84-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Symptom score change and patient versus doctor satisfaction in overactive bladder before and after anti‐muscarinic treatment

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 6, 2015-06 ,pp. : 957-961

John Wiley & Sons Inc

Access to resources Recommend Favorite

Solifenacin for the treatment of overactive bladder

By Robinson Dudley Cardozo Linda

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 691-701

Future Medicine

Access to resources Recommend Favorite

Overactive bladder: diagnosis and treatment

By Vij Monika Robinson Dudley Cardozo Linda

Women's Health, Vol. 6, Iss. 2, 2010-03 ,pp. : 297-310

Future Medicine

Access to resources Recommend Favorite

Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study

By Hill Simon Elhilali Mostafa Millard Richard J Dwyer Peter L Lheritier Karine Kawakami Fernando T. Steel Michael

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2697-2704

Informa Healthcare

Access to resources Recommend Favorite